Loading clinical trials...
Loading clinical trials...
A Phase II Trial of Reduced Intensity Fludarabine and Total Body Irradiation-Based Conditioning Prior to Haplo-Identical Transplantation for Patients With Hematologic Malignancies
Conditions
Interventions
Fludarabine
Locations
1
United States
Caitlin Guzowski
Atlanta, Georgia, United States
Start Date
August 29, 2022
Primary Completion Date
July 31, 2026
Completion Date
December 31, 2026
Last Updated
April 16, 2026
NCT05735717
NCT05529069
NCT07257419
NCT07203534
NCT07052370
NCT07300735
Lead Sponsor
Northside Hospital, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions